wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

[PHARM] Endo 1 GH drugs

Total questions: 18

Worksheet time: 10mins

Name
Class
Date
1.

• Recombinant human IGF-1

• Treatment of severe IGF-1 deficiency that is not responsive to GH

a)

Mecasermine

b)

Sermorelin acetate

c)

Ocreotide

d)

Lanreotide

2.

Adverse effects of Mecasermine

a)

Hypogylcemia

b)

Hyperglycemia

c)

Intracranial hypertension

d)

Adenotonsillar hypertrophy

e)

Increased SGPT & SGOT

3.

What is the most common adverse effect of Mecasermine?

a)

Hypoglycemia

b)

Hyperglycemia

c)

Intracranial hypertension

4.

A carbohydrate-rich food or a snack is taken 20 minutes before/after administration of this drug

a)

Mecasermine

b)

Sermorelin acetate

c)

Octreotide

d)

Lanreotide

5.

Complex of recombinant human IGF-1 (rhIGF-1) and recombinant human insulin-like growth factor binding protein- 3 (rhIGFBP-3)

a)

Mecasermin rinfabate

b)

Sermorelin acetate

6.

• Synthetic GHRH

• Distinguish whether hypothalamic or pituitary deficiency

a)

Mecasermine

b)

Sermorelin acetate

c)

Octreotide

d)

Lanreotide

7.

Synthetic analogs of somatostatin

a)

Mecasermine

b)

Sermorelin acetate

c)

Octreotide

d)

Lanreotide

8.

- Most widely used somatostatin analog

- 45 times more potent than somatostatin in inhibiting GH release

a)

Mecasermine

b)

Octreotide

c)

Lanreotide

d)

Pegvisomant

9.

- Half-life: 80 minutes (30x longer than somatostatin)

- Given 50-200mcg SC every 8 hours

a)

Mecasermine

b)

Octreotide

c)

Lanreotide

d)

Pegvisomant

10.

Therapeutic Uses

- Treatment of Acromegaly

- Sever watery diarrhea (secretory and HIV associated)

- Flushing associated with carcinoid tumors

- Diabetes, Chemotherapy, or Radiation induced

- Portal Hypertension

- Acute control of bleeding esophageal varices

a)

Mecasermine

b)

Sermorelin acetate

c)

Octreotide

d)

Lanreotide

11.

Adverse effects

- Diarrhea

- Abdominal pain

- Flatulence

- Nausea

- Steatorrhea w/ bulky bowel movements

a)

Mecasermine

b)

Octreotide

c)

Lanreotide

d)

Pegvisomant

12.

Adverse effects

Cardiac effects

- Sinus bradycardia

- Conduction disturbance

a)

Mecasermine

b)

Sermorelin acetate

c)

Octreotide

d)

Lanreotide

13.

Adverse effects

- Pain at site of infection

- Vitamin B12 deficiency

a)

Mecasermine

b)

Octreotide

c)

Lanreotide

d)

Pegvisomant

14.

Adverse effects

Long-term use of Somatostatin, ___________, and __________ cause asymptomatic cholesterol gallstones

a)

Mecasermine

b)

Octreotide

c)

Lanreotide

d)

Pegvisomant

15.

Octapeptide somatostatin analog approved for treatment of acromegaly

a)

Mecasermine

b)

Octreotide

c)

Lanreotide

d)

Pegvisomant

16.

Growth Hormone receptor antagonist used to treat acromegaly

a)

Mecasermine

b)

Octreotide

c)

Lanreotide

d)

Pegvisomant

17.

Does not inhibit GH secretion and may lead to increased GH levels and possible adenoma growth

a)

Mecasermine

b)

Octreotide

c)

Lanreotide

d)

Pegvisomant

18.

Adverse effects

No serious problems have been observed however, increases in liver enzymes without liver failure have been reported.

a)

Mecasermine

b)

Octreotide

c)

Lanreotide

d)

Pegvisomant